Long-term outcome of immunomodulator use in pediatric patients with inflammatory bowel disease.
van Hoeve Karen, Hoffman Ilse, D'Hoore André, +2 more·Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
OBJECTIVES: In the era where new biologicals are entering the market, the place of immunomodulators in the treatment of pediatric inflammatory bowel disease (IBD) needs to be reassessed. METHODS: All children with Crohn's disease (CD) or ulcerative colitis (UC) followed at our center over the last 10 years were…